PattonSR, DeLurgioSA, ClementsMA: Evaluation of the Average Daily Risk Range as a measure of glycemic variability in youths with type 1 diabetes. Diabetes Technol Ther, 2015; 17:795–800.
2.
KovatchevBP, OttoE, CoxD, et al.: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care, 2006; 29:2433–2438.
3.
PattonSR, ClementsMA: Average Daily Risk Range as a measure for clinical research and routine care. J Diabetes Sci Technol, 2015; 7:1370–1375.
4.
InzucchiSE, UmpierrezG, DiGenioA, et al.: How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?. Diabetes Res Clin Pract, 2015; 108:179–186.
5.
KovatchevBP, UmpierrezG, DiGenioA, et al.: Sensitivity of traditional and risk-based glycemic variability measures to the effect of glucose-lowering treatment in type 2 diabetes mellitus. J Diabetes Sci Technol, 2015June15 [Epub ahead of print]. doi: 10.1177/1932296815587014.
6.
MonaghanM, YoungeTB, McCarterR, et al.: Average Daily Risk Range (ADRR) in young children with type 1 diabetes. J Diabetes Sci Technol, 2014; 8:70–73.
7.
KovatchevBP, CoxDJ, Gonder-FrederickLA, et al.: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care, 1997; 20:1655–1658.
8.
KovatchevBP, CoxDJ, Gonder-FrederickLA, et al.: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the Low Blood Glucose Index. Diabetes Care, 1998; 21:1870–1875.
9.
KovatchevBP: Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes. Scientifica (Cairo), 2012; 2012:283821.
10.
KovatchevBP, CoxDJ, KumarA, et al.: Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther, 2003; 5:817–828.
11.
KovatchevBP, ClarkeWL, BretonM, et al.: Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther, 2005; 7:849–862.
12.
KovatchevBP, ClarkeWL: Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology. J Diabetes Sci Technol, 2008; 2:158–163.
13.
CobelliC, Dalla ManC, SparacinoG, et al.: Diabetes: models, signals, and control. IEEE Rev Biomed Eng, 2009; 2:54–96.
14.
HughesCS, PatekSD, BretonMD, et al.: Hypoglycemia prevention via pump attenuation and red-yellow-green “traffic” lights using continuous glucose monitoring and insulin pump data. J Diabetes Sci Technol, 2010; 4:1146–1155.
15.
SchlichtkrullJ, MunckO, JersildM: The M-value, an index of blood-sugar control in diabetics. Acta Med Scand, 1965; 177:95–102.
16.
ServiceFJ, MolnarGD, RosevearJW, et al.: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes, 1970; 19:644–655.
17.
RyanEA, ShandroT, GreenK, et al.: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes, 2004; 53:955–962.
18.
ZisserHC, BiersmithMA, JovanovicLB, et al.: Fetal risk assessment in pregnancies complicated by diabetes mellitus. J Diabetes Sci Technol, 2010; 4:1368–1373.
